Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort descending
Aug
31
2022
All Federal Research Agencies to Update Public Access Policies K&L Gates
Jun
28
2023
Litigation Minute: FDA and State Action on PFAS in Food Packaging K&L Gates
Dec
11
2020
HRSA Publishes Long-Awaited (and Long-Overdue) 340 B Program Alternative Dispute Resolution Process Final Rule K&L Gates
Dec
22
2020
340b Update: Recent Supreme Court Ruling May Curtail 340b Program Discriminatory Pricing K&L Gates
Apr
2
2024
Litigation Minute: Class-Action Challenges to Natural and Clean Beauty Product Claims K&L Gates
Apr
30
2024
Carbon Quarterly - Volume 8 K&L Gates
Apr
7
2021
Impact of the Growing Marketing Authorization Holder Pilot Program in China's Medical Device Industry K&L Gates
Jul
18
2022
Commission Approves State Aid For IPCEI In Hydrogen K&L Gates
Jul
25
2023
Real Estate Beneficial Ownership Regulatory Alert: Complying with Foreign Ownership Reporting Requirements in US Real Estate K&L Gates
Apr
24
2020
Court of Chancery Holds That Sole, Conflicted General Partner Cannot, By Reason of Conflict, Delegate Its other Valid Power to Manage Derivative Litigation K&L Gates
Jul
21
2020
340b Update: HRSA Indicates It Lacks Authority to Enforce 340b Program Guidance K&L Gates
Dec
1
2023
Burger Wars: The big Beef Between McDonald’s and Hungry Jack’s – McD Asia Pacific LLC v Hungry Jack’s Pty Ltd [2023] FCA 1412 K&L Gates
Jan
11
2017
Australia Trademark Dispute: An Apple a Day Doesn’t Keep Litigation at Bay K&L Gates
Jan
17
2017
Medical Marijuana Comes to Pennsylvania: What to Expect As the Keystone State Rolls Out its New Medical Marijuana Program K&L Gates
Aug
4
2017
Employees Celebrate Chip Party: Embedding RFID Chips – Would You Agree to This? K&L Gates
Jan
12
2022
CMS Proposes Rule to Lower Part D Drug Costs for Beneficiaries K&L Gates
Jul
13
2022
The FTC's "New" Tool: Greater Enforcement of the Robinson-Patman Act K&L Gates
Jul
27
2020
President Trump Signs Drug Pricing Executive Orders Reinforcing the Administration's Priorities K&L Gates
Sep
26
2020
340B UPDATE: Congress and the Administration Respond to Drug Manufacturers' 340B Contract Pharmacy Actions K&L Gates
Apr
19
2017
Abbott Labs Makes Costly Mistake as FDA Targets Cybersecurity Deficiencies K&L Gates
Apr
2
2021
Cannabis Banking; The SAFE Banking Act 2.0's Status, Key Modifications, and Prospects K&L Gates
Nov
3
2017
Impact of Cyberattack on Merck was $135 million K&L Gates
Aug
3
2022
What The Fudge?! Popular Breakfast Snack’s Lack Of Key Ingredient Did Not Trigger Liability Under State Consumer Fraud And Magnuson-moss Warranty Acts K&L Gates
Sep
20
2023
Ninth Circuit Finds that Costco Is Not Just a Retailer, but Actively Competes with Wholesalers with Respect to Robinson-Patman Price Discrimination Claims K&L Gates
Apr
23
2024
Litigation Minute: The Lifecycle of Beauty Packaging K&L Gates
Jul
26
2017
Massachusetts’s Highest Court Rules that Employee Fired for Medical Marijuana Use Can Hold Employer Liable for Discrimination K&L Gates
Jul
1
2021
More than Innovation and Competition: The Latest Proposed Monitoring and Enforcement Mechanisms Targeting Foreign Influence in U.S. Research K&L Gates
Jul
8
2021
340B Update: Supreme Court Accepts Certiorari in 340B Payment Reduction Case K&L Gates
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins